Mezzion Pharma Co.,Ltd.

140410.KQ

140410.KQMezzion Pharma Co.,Ltd. KR flag

KOSDAQ

36,750.00

KRW

-1,200.00

(-3.16%)

1.10TMarket Cap

May 13Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

Mezzion Pharma Co.,Ltd.

140410.KQ

(KOSDAQ)

Recent

price

36,750.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

Legends:

Stock price

Beta (1.0 Market)

% total return 05/12

Stock

S&P500

-1.21

8.32

116.18

43.81

-40.11

96.82

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	TTM
1,074.48	1,343.19	279.34	378.33	201.37	212.49	659.85	395.84	250.23	766.14	689.8	1,100.84	998.74	1,149.55	1,123.96	- -	291.18	Revenue per Share
674	905.67	176.67	105	-38	-112.33	186.67	-587.33	-666.67	-757.67	-895	-531.67	-509.7	-1,358	-451	- -	-658.55	Basic EPS, GAAP
684.25	934.12	-101.45	130.84	-162.99	-207.96	53.41	-282.53	-683.71	-894.93	-846	-589.48	-796.4	-517.63	-810.75	- -	-1,080.92	Free Cash Flow per Basic Share
- -	- -	- -	- -	8.34	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Dividend per Share
167.72	1,064.28	1,248.71	1,133.11	1,122.61	957.4	1,146.55	632.55	-42.72	-795.17	-1,655.81	-2,180.6	-2,635.63	-3,654.53	-3,859.3	- -	-4,333.61	Book Value per Share
480.6	1,367.68	1,499.22	2,741.06	2,794.53	2,761.44	2,652.65	2,374.84	2,308.6	2,235.07	1,586.29	1,867.2	1,821.64	921.11	1,718.52	- -	595.88	Tangible Book Value per Share
17	18	18	23	22	23	23	22	22	25	26	26	27	27	28	- -	30	Basic Weighted Avg Shares
18,443	24,379	5,067	8,592	4,402	4,857	14,926	8,751	5,586	19,088	17,920	28,634	26,654	30,726	31,721	8,612	8,612	Sales/Revenue/Turnover
70.34	71.85	55.82	19.56	-56.17	-101.22	-18.31	-82.5	-301.59	-114.87	-136.62	-26.3	-63.02	-75.93	-45.68	-166.05	-166.05	Operating Margin (%)
95	55	40	49	48	151	343	415	62	228	1,332	1,432	1,586	1,658	1,546	958	958	Depreciation Expense
11,569	16,438	3,204	2,385	-831	-2,568	4,223	-12,985	-14,882	-18,876	-23,251	-13,829	-13,603	-36,298	-12,728	-19,477	-19,477	Net Income, GAAP
- -	15.04	21.69	20.49	- -	- -	18.19	- -	- -	- -	- -	- -	- -	- -	- -	- -	63.96	Effective Tax Rate (%)
62.73	67.43	63.24	27.75	-18.87	-52.86	28.29	-148.38	-266.42	-98.89	-129.75	-48.3	-51.03	-118.13	-40.13	-226.17	-226.17	Profit Margin (%)
4,815	16,330	16,831	56,626	58,103	62,804	83,609	77,713	50,007	52,278	38,339	45,155	45,678	19,817	44,628	15,255	15,255	Working Capital
- -	- -	- -	- -	- -	- -	25,236	26,255	- -	- -	2,420	3,104	2,338	1,625	1,005	921	921	LT Debt
8,249	24,824	28,170	63,336	62,177	66,151	62,537	52,809	53,169	57,319	42,830	56,810	62,793	26,240	61,444	46,063	46,063	Total Equity
- -	81.7	7.99	2.92	- -	- -	-2.91	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Invested Capital (%)
- -	148.12	15.27	9.86	- -	- -	14.78	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.77	Return on Capital (%)
- -	148.12	15.27	9.86	-3.3	-11.06	17.66	-65.05	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Common Equity (%)

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	36.39%	-0.29%	-72.85%
Net Income, GAAP	-49.45%	22.55%	53.02%
Free Cash Flow	-47.48%	15.72%	39.71%
Total Cash Common Dividend	- -	- -	- -
Total Equity	5.63%	18.82%	-25.03%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Similar Companies: Sydinvest HøjrenteLande (SYIHYADKK.CO)
LEVERAGE SHARES PUBLIC LIMITED (BID1.L)
Western Australia Energy Resources Limited (WER.AX)
Intralinks Holdings, Inc. (IL)
GrandSouth Bancorporation PFD SER A (GRRBP)
Medivolve Inc (MEDVD)
Business

	Jun'24	Sep'24	Dec'24
ST Debt	732	651	694
LT Borrowings	- -	- -	- -
LT Finance Leases	- -	812	921
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	30	30	30
Market Capitalization	1,095,421	801,484	912,390

	Jun'24	Sep'24	Dec'24
Total Current Assets	56,907	50,330	41,926
Accounts Receivable, Net	1,131	1,376	870
Cash, Cash Equivalents & STI	41,122	34,727	28,617
Inventories	5,521	5,493	5,420
Total Current Liabilities	21,491	19,547	26,670
Payables & Accruals	- -	- -	- -
ST Debt	732	651	694
Deferred Revenue	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	6,682	8,259	8,015	7,769	30,726
2023	7,788	8,113	8,430	7,390	31,721
2024	2,158	2,269	2,261	1,924	8,612

Year	Q1	Q2	Q3	Q4	FY
2022	- -	- -	- -	- -	- -
2023	- -	- -	- -	- -	- -
2024	- -	- -	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	-52.33	-604	81	- -	-1,358
2023	-93	-107	-33	- -	-451
2024	- -	-55	-213	- -	- -

2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	TTM
1,074.48	1,343.19	279.34	378.33	201.37	212.49	659.85	395.84	250.23	766.14	689.8	1,100.84	998.74	1,149.55	1,123.96	- -	291.18	Revenue per Share
674	905.67	176.67	105	-38	-112.33	186.67	-587.33	-666.67	-757.67	-895	-531.67	-509.7	-1,358	-451	- -	-658.55	Basic EPS, GAAP
684.25	934.12	-101.45	130.84	-162.99	-207.96	53.41	-282.53	-683.71	-894.93	-846	-589.48	-796.4	-517.63	-810.75	- -	-1,080.92	Free Cash Flow per Basic Share
- -	- -	- -	- -	8.34	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Dividend per Share
167.72	1,064.28	1,248.71	1,133.11	1,122.61	957.4	1,146.55	632.55	-42.72	-795.17	-1,655.81	-2,180.6	-2,635.63	-3,654.53	-3,859.3	- -	-4,333.61	Book Value per Share
480.6	1,367.68	1,499.22	2,741.06	2,794.53	2,761.44	2,652.65	2,374.84	2,308.6	2,235.07	1,586.29	1,867.2	1,821.64	921.11	1,718.52	- -	595.88	Tangible Book Value per Share
17	18	18	23	22	23	23	22	22	25	26	26	27	27	28	- -	30	Basic Weighted Avg Shares
18,443	24,379	5,067	8,592	4,402	4,857	14,926	8,751	5,586	19,088	17,920	28,634	26,654	30,726	31,721	8,612	8,612	Sales/Revenue/Turnover
70.34	71.85	55.82	19.56	-56.17	-101.22	-18.31	-82.5	-301.59	-114.87	-136.62	-26.3	-63.02	-75.93	-45.68	-166.05	-166.05	Operating Margin (%)
95	55	40	49	48	151	343	415	62	228	1,332	1,432	1,586	1,658	1,546	958	958	Depreciation Expense
11,569	16,438	3,204	2,385	-831	-2,568	4,223	-12,985	-14,882	-18,876	-23,251	-13,829	-13,603	-36,298	-12,728	-19,477	-19,477	Net Income, GAAP
- -	15.04	21.69	20.49	- -	- -	18.19	- -	- -	- -	- -	- -	- -	- -	- -	- -	63.96	Effective Tax Rate (%)
62.73	67.43	63.24	27.75	-18.87	-52.86	28.29	-148.38	-266.42	-98.89	-129.75	-48.3	-51.03	-118.13	-40.13	-226.17	-226.17	Profit Margin (%)
4,815	16,330	16,831	56,626	58,103	62,804	83,609	77,713	50,007	52,278	38,339	45,155	45,678	19,817	44,628	15,255	15,255	Working Capital
- -	- -	- -	- -	- -	- -	25,236	26,255	- -	- -	2,420	3,104	2,338	1,625	1,005	921	921	LT Debt
8,249	24,824	28,170	63,336	62,177	66,151	62,537	52,809	53,169	57,319	42,830	56,810	62,793	26,240	61,444	46,063	46,063	Total Equity
- -	81.7	7.99	2.92	- -	- -	-2.91	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Invested Capital (%)
- -	148.12	15.27	9.86	- -	- -	14.78	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.77	Return on Capital (%)
- -	148.12	15.27	9.86	-3.3	-11.06	17.66	-65.05	- -	- -	- -	- -	- -	- -	- -	- -	- -	Return on Common Equity (%)

Mezzion Pharma Co.,Ltd.

Growth Rates

(avg. rate of change)

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year

Quarterly Earnings Per Share

Year